Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Senti, Gabriela; von Moos, Seraina; Tay, Fabian; Graf, Nicole; Johansen, Pål; Kündig, Thomas M (2015). Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy, 70(6):707-710.

von Moos, Seraina; Johansen, Pål; Tay, Fabian; Graf, Nicole; Kündig, Thomas M; Senti, Gabriela (2014). Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy. Journal of Allergy and Clinical Immunology, 134(4):965-967.e4.

Senti, Gabriela; von Moos, Seraina; Kündig, Thomas M (2014). Epicutaneous immunotherapy for aeroallergen and food allergy. Current Treatment Options in Allergy, 1(1):68-78.

Waeckerle-Men, Ying; Liang, Yuan; von Moos, Seraina; Kündig, Thomas M; Johansen, Pål (2014). Multivalent paediatric allergy vaccines protect against allergic anaphylaxis in mice. Clinical and Experimental Allergy, 44(3):429-437.

von Moos, Seraina; Franzen, Daniel; Kupferschmidt, Hugo (2013). Inhalationstrauma. Praxis, 102(14):829-839.

von Moos, Seraina; Graf, Nicole; Johansen, Pål; Müllner, Gerhard; Kündig, Thomas M; Senti, Gabriela (2013). Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy. International Archives of Allergy and Immunology, 160(1):86-92.

Senti, Gabriela; von Moos, Seraina; Tay, Fabian; Graf, Nicole; Sonderegger, Theodor; Johansen, Pål; Kündig, Thomas M (2012). Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study. Journal of Allergy and Clinical Immunology, 129(1):128-135.

Johansen, Pål; von Moos, Seraina; Mohanan, Deepa; Kündig, Thomas M; Senti, Gabriela (2012). New routes for allergen immunotherapy. Human Vaccines & Immunotherapeutics, 8(10):1525-1533.

This list was generated on Sat Apr 20 06:24:31 2019 CEST.